# Harrow share price today (Harrow, Inc., HROW)

> Harrow, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. HROW · Healthcare · Drug Manufacturers - Specialty & Generic · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/hrow

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: $28.54 (−24.4% in a year)
- Revenue (Jun 2026): $70.7 M (+10.9% on a year ago)
- Profit (Jun 2026): −$17.3 M (−445.7% on a year ago)
- Operating margin: −15.6% (−33.5 points on a year ago)
- ROE: −10%, FY25
- ROIC: −1.2%, against a 5.4% cost of capital: −6.6 points

Biggest thing to watch: margins are the best this company has ever reported. Every ratio looks better at a record, so the story depends on margins staying high. ## What is the Harrow share price today? Harrow, Inc.'s share price was $28.54 at the close on 3 November 2026. That is 25.2% below its average price over the last 200 trading days. In the last 52 weeks it traded between $27 and $54, and at that close it sat 5% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 9 weeks running. Over the last 1 year the share price moved −18% while the S&P 500 moved +21%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 4 September 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Harrow pay? Harrow, Inc. pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes. ## Which stock lists is Harrow on? Harrow is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Harrow profitable? Harrow, Inc. posted a net loss of $17.3 M in the Jun 2026 quarter. The full FY25 year was a loss of $5.1 M. That loss is 24.4% of the quarter's revenue. The same quarter a year earlier earned $5.0 M. 8 of the last 12 reported quarters were loss-making. Jun 2026 profit was −$17.3 M, −445.7% on a year earlier. ## How much revenue does Harrow make, and is it growing? Harrow, Inc. reported $70.7 M of revenue in the Jun 2026 quarter, +10.9% on the same quarter a year earlier. Over 4 years it has grown 39.2% a year on average. The last full year, FY25, came in at $272 M. The last four reported quarters add to $276 M. FY25 revenue was $272 M, +36.4% on the year before. Recent pace: the last four quarters grew +20.5% on average, against 39.2% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +21.1%, against +33.7% a year over the last 8 quarters (rolling over). ## How much of every $100 of sales does Harrow keep? Harrow, Inc.'s operating margin was −15.6% in the Jun 2026 quarter, 33.5 percentage points lower than the same quarter a year ago. Its latest full-year margin is the highest it has ever reported. Across 5 years it has been between 0.6% and 11.2%. The latest quarter is below every full year in that period. Across 5 years it has been between 0.6% and 11.2%, and FY25's 11.2% is the highest of them. Why the margin moved: operating margin changed −33.5 percentage points on the year while gross margin changed −3.2 points. So the drop came mostly from costs below the gross margin, such as staff and overheads, measured against sales. When margins are at a record, every ratio built on profit looks better than usual, so watch whether they hold. ## Is Harrow's profit turning into cash? Harrow, Inc.'s cash-flow history is too short to judge how much of its profit turns into cash. In FY25 it brought in $43.9 M of operating cash against −$5.1 M of profit. After $887 K of spending on assets, $43.0 M was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Harrow's cash go? Harrow, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $3.9 M on assets over the last 3 years. Averaged over those years that is 0.5% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $3.9 M over the last 3 years. In short: most of the cash goes on covering the loss, not on new assets; spending on assets is small next to it. ## What is Harrow's P/E ratio, and how does it compare with its own history? Harrow, Inc. has no P/E right now, because its earnings are negative. The revenue and margin sections are where a turn would show first. Measured against sales instead, the market values Harrow, Inc. at 3.9× its FY25 revenue of $272 M. The P/E comes back here once profit turns positive. ## Is the Harrow business getting better or worse? Harrow, Inc.'s business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 12 quarters of 2 measures, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Harrow earn on its capital? Harrow, Inc. earned a ROE of −10% in FY25. That is up from a low of −169% in FY21. Its return on capital used (ROIC) is 6.6 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a −1.9% net margin and 0.68× asset turnover (sales divided by assets). Why the return is what it is (FY25): a −1.9% net margin × 0.68× asset turnover × 7.67× leverage (assets divided by equity) ≈ −9.9% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: −1.2% − 5.4% = −6.6 percentage points. The 5.4% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. ## Does Harrow have too much debt? Harrow, Inc. has total debt of $301 M against shareholder equity of $14.8 M as of Jun 2026, so its debt is 20.26× its equity. Year by year, that ratio went from 7.13 in FY21 to 4.84 in FY25. Keep that borrowing in mind when reading the returns on this page. ## What is the Harrow shareholding pattern? 25.8% of Harrow, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so a large group of traders is betting against it. At normal trading volumes, closing those positions would take about 11.5 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Harrow from balance-sheet trouble? For Harrow, Inc., the Z-score is 2.55. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the grey area between the two. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 2.55 is in the grey area, neither clearly safe nor clearly in trouble. ## How does Harrow rank in its industry? There is no score against its industry: Harrow, Inc. is not among the largest members shown in this industry comparison for Drug Manufacturers - Specialty & Generic. The score ranks a company within its industry: each measure is scored against the other members. Without that group there is no score, so none is shown. ## Which companies is Harrow compared with? No sector comparison is shown here, not among the largest members shown in this industry comparison. ## Which companies are close to Harrow in size? Harrow is the 33rd largest of 51 Drug Manufacturers - Specialty & Generic companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Pacira BioSciences, Inc., Cronos Group Inc. and Amphastar Pharmaceuticals, Inc. Just below it: Esperion Therapeutics, Inc., Collegium Pharmaceutical, Inc. and Ironwood Pharmaceuticals, Inc. ### Drug Manufacturers - Specialty & Generic companies close in size

1. [Pacira BioSciences, Inc.](https://www.sectoralpha.in/us/stocks/pcrx) $1.5 billion
2. [Cronos Group Inc.](https://www.sectoralpha.in/us/stocks/cron) $1.3 billion
3. [Amphastar Pharmaceuticals, Inc.](https://www.sectoralpha.in/us/stocks/amph) $1.2 billion
4. Harrow, Inc. $1.1 billion
5. [Esperion Therapeutics, Inc.](https://www.sectoralpha.in/us/stocks/espr) $819 million
6. [Collegium Pharmaceutical, Inc.](https://www.sectoralpha.in/us/stocks/coll) $773 million
7. [Ironwood Pharmaceuticals, Inc.](https://www.sectoralpha.in/us/stocks/irwd) $578 million

[All 51 Drug Manufacturers - Specialty & Generic companies, largest first](https://www.sectoralpha.in/us/sectors/drug-manufacturers-specialty-generic#all-companies)

### Companies close in size in other industries

1. [HealthStream, Inc.](https://www.sectoralpha.in/us/stocks/hstm) $1.1 billion · Health Information Services
2. [Karat Packaging Inc.](https://www.sectoralpha.in/us/stocks/krt) $1.1 billion · Packaging & Containers
3. Harrow, Inc. $1.1 billion
4. [MetroCity Bankshares, Inc.](https://www.sectoralpha.in/us/stocks/mcbs) $1.1 billion · Banks - Regional
5. [Riley Exploration Permian, Inc.](https://www.sectoralpha.in/us/stocks/repx) $1.1 billion · Oil & Gas Exploration & Production

## What else do people ask about Harrow? ### What were Harrow's latest quarterly results? Harrow, Inc. reported revenue of $70.7 M and a net loss of $17.3 M for the Jun 2026 quarter. Revenue rose 10.9% and profit fell 445.7% compared with a year earlier. Earnings per share were −$0.46. The operating margin was −15.6%, 33.5 percentage points lower than a year earlier (as of 3 November 2026). ### What is Harrow's market cap? Harrow, Inc.'s market capitalisation is $1.1 B at a stock price of $28.54. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Harrow performing? Harrow, Inc.'s latest readings are below. In its latest quarter, revenue rose 10.9% and profit fell 445.7% compared with a year earlier. Over the past 13 weeks it has done worse than the S&P 500, for 9 weeks running. This describes what the data did, not a rating (as of 3 November 2026). ### Will Harrow's stock price go up? This page does not forecast Harrow, Inc.'s stock price. What it shows instead: the stock price is $28.54. Nobody can reliably say which way a price will move, and this site does not try (as of 3 November 2026). ### Where is Harrow in its business cycle? Harrow, Inc.'s FY25 operating margin was 11.2%, against a 5-year range of 0.6% to 11.2%: the top of its range, a record year. When profit is at a record, every ratio looks better than usual, and the story depends on margins staying high. The latest quarter was −15.6%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Harrow story? Biggest thing to watch: margins are the best this company has ever reported. Every ratio looks better at a record, so the story depends on margins staying high. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Harrow a stock worth studying right now? What the numbers show: Harrow, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.